mRNA platform company
Sensible Biotechnologies has raised €3.8M across 1 funding round from 8 investors, most recently a Pre-Seed round in Apr 2023. Based in Oxford, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-04-06 | Pre-Seed |
| €3.8M |
| Amino Collective,BlueYard Capital,Civilization Ventures,Florian Schuster,Jason C. Foster,Recode Health Ventures+2 more |
| View deal → |
